IL13RA2 and neoplasm: In the current study, we report the development of a novel IL‐13Rα2‐specific CAR (IL‐13Rα2‐CAR‐T cells) with an improved scFv‐based antigen binding domain that provides better recognition of IL‐13Rα2 on the tumour cell surface.